|
SGCB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.211600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.381600E-01 |
| Normal-vs-Stage2 |
9.753800E-01 |
| Normal-vs-Stage3 |
8.026600E-01 |
| Normal-vs-Stage4 |
2.173400E-01 |
| Stage1-vs-Stage2 |
5.486800E-01 |
| Stage1-vs-Stage3 |
5.005000E-01 |
| Stage1-vs-Stage4 |
4.480400E-01 |
| Stage2-vs-Stage3 |
8.527400E-01 |
| Stage2-vs-Stage4 |
3.182200E-01 |
| Stage3-vs-Stage4 |
3.904400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.755600E-01 |
| Normal-vs-AfricanAmerican |
3.653200E-01 |
| Normal-vs-Asian |
6.843800E-01 |
| Caucasian-vs-AfricanAmerican |
7.432600E-01 |
| Caucasian-vs-Asian |
7.547400E-01 |
| AfricanAmerican-vs-Asian |
8.044800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.995800E-01 |
| Normal-vs-Female |
4.077400E-01 |
| Male-vs-Female |
7.991600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.843800E-02 |
| Normal-vs-Extreme_Weight |
1.668970E-01 |
| Normal-vs-Obese |
5.925200E-01 |
| Normal-vs-Extreme_Obese |
9.033400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.109200E-01 |
| Normal_Weight-vs-Obese |
2.914400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.269000E-01 |
| Extreme_Weight-vs-Obese |
5.185200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.253200E-01 |
| Obese-vs-Extreme_Obese |
8.773000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.678000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.885800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.741700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.724200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.823940E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.108000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.082000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.318100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.546000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.048200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.439600E-01 |
| Normal-VS-Type2 PRCC |
8.422800E-01 |
| Normal-VS-KIRP CIMP |
3.66679999996844E-06 |
| Normal-VS-Unclassified PRCC |
9.300200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.646400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.232330E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.600600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.020500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.456000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.371770E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.992200E-01 |
| Normal-vs-N1 |
5.715600E-01 |
| Normal-vs-N2 |
2.979600E-04 |
| N0-vs-N1 |
7.461200E-01 |
| N0-vs-N2 |
1.962960E-01 |
| N1-vs-N2 |
5.626400E-02 |
|
|
